Orthopedics This Week
Tuesday, March 31, 2026Vol. 22, No. 4
Breaking
First Subjects Randomized in Clinical Trial Evaluating the Benefits of Total Segmental Fusion in Treating Degenerative Conditions in the Lumbar Spine|Fziomed Announces Clinical Results from Level I Study Evaluating Oxiplex Absorbable Gel for Spine Surgery|OSSIOfiber® Minimally Invasive All-Natural Bunion Correction System Improves, Simplifies Surgical Procedure for Patients and Physicians
Today's Top StoriesMore
Premium Subscription

Full access to all articles, archives, and exclusive analysis.

Monthly
$24.99/mo
Subscribe Now

Or sign in if you're a member

Newsletter

Weekly orthopedic industry digest, every Friday.

TOPS System: Posterior Facet Arthroplasty Outperforms TLIF
Spine

TOPS System: Posterior Facet Arthroplasty Outperforms TLIF

For decades, the surgical treatment of degenerative lumbar spondylolisthesis has lived in a philosophical tug-of-war.

Mar 27, 2026
Stratus Medical Recognized on Fortune’s America’s Most Innovative Companies List for 2026
Company News

Stratus Medical Recognized on Fortune’s America’s Most Innovative Companies List for 2026

Stratus® Medical, a company focused on advancing radiofrequency ablation (RFA) treatment for chronic pain, has been named to America’s Most Innovative Companies 2026 by Fortune.

Mar 26, 2026
First Subjects Randomized in Clinical Trial Evaluating the Benefits of Total Segmental Fusion in Treating Degenerative Conditions in the Lumbar Spine
Spine

First Subjects Randomized in Clinical Trial Evaluating the Benefits of Total Segmental Fusion in Treating Degenerative Conditions in the Lumbar Spine

Providence Medical Technology’s latest randomized controlled trial is designed to once again challenge the standard of care in spinal fusion surgery.

Mar 26, 2026
More StoriesMore
Scoliosis, the Clock, and the Quality-of-Life Curve
SpineMar 25

Scoliosis, the Clock, and the Quality-of-Life Curve

When is the optimal moment to stop watching the scoliotic curve and operate?

Gabapentin After ACDF: Friend, Foe…or Frenemy?
SpineMar 25

Gabapentin After ACDF: Friend, Foe…or Frenemy?

Time to stop using gabapentin after ACDF?

Tetrous® Strengthens Commercial Leadership with Appointment of Thurman Ballard as Vice President of Sales
Company NewsMar 25

Tetrous® Strengthens Commercial Leadership with Appointment of Thurman Ballard as Vice President of Sales

Tetrous, Inc. announced the appointment of Thurman Ballard as Vice President of Sales.

People in the NewsMore
Subscribe